Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Herpes simplex: treatment today

D D Nuss, J L Aeling

    Cutis
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    No current topical or systemic therapies are proven safe and effective for recurrent mucocutaneous herpes simplex infections. Recent flexible collodion treatments are under review for this persistent viral condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Images in clinical medicine. Furuncular myiasis.

    The New England journal of medicine·2000
    Same author

    Acute pyoderma gangrenosum does not require surgical therapy.

    Archives of family medicine·1998
    Same author

    Solitary wrist plaque in an infant. Infantile myofibromatosis.

    Archives of dermatology·1998
    Same author

    Solitary congenital nodule in an infant. Solitary congenital self-healing reticulohistiocytosis (CSHR).

    Archives of dermatology·1998
    Same author

    Lesion size is a factor for determining the rate of port-wine stain clearing following pulsed dye laser treatment in adults.

    Cutis·1997
    Same author

    Reactive perforating collagenosis in Treacher Collins syndrome.

    Journal of the American Academy of Dermatology·1996
    Same journal

    Black Dots on the Scalp of a Child.

    Cutis·2026
    Same journal

    Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

    Cutis·2026
    Same journal

    Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

    Cutis·2026
    Same journal

    The Future of Psoriasis Care.

    Cutis·2026
    Same journal

    Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

    Cutis·2026
    Same journal

    Metastatic Primary Extramammary Paget Disease: A Case Series.

    Cutis·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Infectious Diseases
    • Virology

    Background:

    • Recurrent mucocutaneous herpes simplex virus (HSV) infections pose a significant therapeutic challenge.
    • Existing treatments lack definitive scientific validation for safety and efficacy in double-blind studies.
    • The need for effective management strategies for mucocutaneous HSV is ongoing.

    Purpose of the Study:

    • To review past and current therapeutic options for recurrent mucocutaneous herpes simplex infections.
    • To evaluate the evidence supporting the safety and efficacy of existing treatments.
    • To discuss emerging treatment modalities.

    Main Methods:

    • Comprehensive literature review of past and current therapies.
    • Analysis of scientific double-blind studies on mucocutaneous herpes simplex treatments.

    Related Experiment Videos

  • Discussion of recent treatment approaches, including flexible collodion.

    • Main Results:

    • No topical or systemic therapy has been conclusively demonstrated as safe and effective through rigorous scientific double-blind studies.
    • Current therapeutic landscape for recurrent mucocutaneous HSV is characterized by unproven treatments.
    • Flexible collodion represents a recent therapeutic consideration requiring further investigation.

    Conclusions:

    • There is a critical unmet need for evidence-based, safe, and effective therapies for recurrent mucocutaneous herpes simplex.
    • Further rigorous clinical trials are essential to validate existing and novel treatment strategies.
    • The review highlights the limitations of current management and the importance of continued research in this area.